What is the significance of a serum iron of 149 µg/dL and a total iron‑binding capacity of 306 µg/dL with otherwise normal laboratory results, and what are the appropriate next diagnostic and management steps?

Interpretation and Management of Iron Studies

Your transferrin saturation is 49% (149/306), which is elevated and warrants further evaluation with serum ferritin measurement and consideration of genetic testing for hereditary hemochromatosis.

Understanding Your Results

Your iron studies show:

• Serum iron: 149 µg/dL (normal range typically 60-170 µg/dL)
• TIBC: 306 µg/dL (normal range typically 240-450 µg/dL)
• Calculated transferrin saturation: 49%

The transferrin saturation of 49% exceeds the screening threshold of 45% used to identify potential iron overload, particularly hereditary hemochromatosis 1, 2.

Clinical Significance

Transferrin saturation is the preferred screening test for iron overload states 1. While a single elevated value can occur due to diurnal variation or recent iron intake 3, a fasting transferrin saturation ≥45% should trigger further investigation 1.

The 2011 AASLD guidelines note that while fasting samples were previously recommended, recent studies show no significant improvement in sensitivity or specificity. However, confirming an elevated transferrin saturation with a second determination is advisable, ideally on a fasting specimen 2.

Immediate Next Steps

1. Measure Serum Ferritin

This is critical for determining the clinical significance of your elevated transferrin saturation 1, 2, 4:

• If ferritin is normal (<200 µg/L in women, <300 µg/L in men): Risk of significant iron overload is low, but repeat testing in 6-12 months is reasonable
• If ferritin is elevated (>200 µg/L in women, >300 µg/L in men): Proceed to genetic testing 2, 4

Important caveat: Ferritin is an acute-phase reactant and can be falsely elevated by infection, inflammation, liver disease, alcohol use, malignancy, or chronic inflammatory conditions 3, 2. These conditions must be excluded when interpreting elevated ferritin.

2. Confirm with Repeat Testing

Given the significant day-to-day variability in serum iron and transferrin saturation 3, repeat the transferrin saturation measurement (preferably fasting) before proceeding with expensive genetic testing 2.

3. Genetic Testing for Hemochromatosis

If both transferrin saturation remains ≥45% and ferritin is elevated on repeat testing, HFE gene testing for C282Y and H63D mutations should be performed 1, 2, 4:

• C282Y homozygotes with elevated iron markers require phlebotomy therapy
• C282Y/H63D compound heterozygotes may have mild iron overload
• H63D homozygotes rarely develop significant iron overload unless other risk factors are present

The 2022 EASL guidelines recommend genetic testing for individuals of European origin with transferrin saturation >50% in men or >45% in women, combined with elevated ferritin 4.

Risk Stratification

If you are C282Y homozygous with elevated iron markers:

• Age <40 years, no liver disease symptoms, ferritin <1,000 ng/mL: Proceed directly to therapeutic phlebotomy without liver biopsy 1, 2
• Ferritin >1,000 ng/mL or elevated liver enzymes: Consider liver biopsy or MRI to assess for cirrhosis, as ferritin >1,000 ng/mL predicts advanced fibrosis 2, 1, 2

Common Pitfalls to Avoid

1. Don't ignore an isolated elevated transferrin saturation - While it may be transient, it requires confirmation and ferritin measurement 1, 2

2. Don't assume elevated ferritin always means iron overload - Rule out inflammation, infection, liver disease, and malignancy first 3, 2

3. Don't delay genetic testing if both markers are persistently elevated - Early diagnosis and treatment before cirrhosis develops dramatically improves outcomes and prevents hepatocellular carcinoma 2, 1

4. Don't perform genetic testing without informed consent - Discuss implications for insurance, family screening, and psychological impact 5, 4

Family Screening

If you are diagnosed with hereditary hemochromatosis (C282Y homozygous), all first-degree adult relatives (>18 years) should undergo genetic testing for the C282Y mutation 1, 4. They should have transferrin saturation and ferritin measured if positive 1.

Bottom Line Algorithm

1. Repeat fasting transferrin saturation + measure serum ferritin
2. If both remain elevated → HFE genetic testing (C282Y, H63D)
3. If C282Y homozygous → Assess for liver disease (clinical exam, liver enzymes)
4. If ferritin <1,000 ng/mL and age <40 with no liver disease → Begin therapeutic phlebotomy
5. If ferritin >1,000 ng/mL or liver disease present → Liver imaging (MRI) or biopsy before phlebotomy

Your transferrin saturation of 49% places you above the screening threshold and requires systematic evaluation to determine if hereditary hemochromatosis or another cause of iron overload is present 1, 2, 4.